Claire Piccinin

Claire Piccinin

Auto-generated profile, based on publicly available information

Claire Piccinin

Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2021 in Quality of Life Research
Verified
Journal Article
Open access
PDF file
CACecilie Delphin Amdal
Cecilie Delphin Amdal
MPMadeline Pe
Madeline Pe
RFRagnhild Sørum Falk
Ragnhild Sørum Falk
CPClaire Piccinin
Claire Piccinin
ABAndrew Bottomley
Andrew Bottomley
KBKristin Bjordal
Kristin Bjordal
Purpose: This systematic review was performed to identify all relevant health-related quality of life (HRQoL) issues associated with COVID-19. Methods: A systematic literature search was undertaken in April 2020. In four teams of three reviewers each, all abstracts were independently reviewed for inclusion by two reviewers. Using a pre-defined checklist of 93 criteria for each publication, data extraction was performed independently by two reviewers and subsequently compared and discussed. If necessary, a third reviewer resolved any discrepancies. The search was updated in February 2021 to retrieve new publications on HRQoL issues including issues related to the long-term consequences of COVID-19. Results: The search in April 2020 identified 3342 potentially relevant publications, and 339 publications were selected for full-text review and data extraction. We identified 75 distinct symptoms and other HRQoL issues categorized into 12 thematic areas; from general symptoms such as fever, myalgia, and fatigue, to neurological and psychological issues. The updated search revealed three extra issues experienced during active disease and long-term problems with fatigue, psychological issues and impaired cognitive function. Conclusion: This first comprehensive systematic review provides a detailed overview of the wide range of HRQoL issues experienced by patients with COVID-19 throughout the course of the disease. It demonstrates the devastating impact of the disease and provides critically important information for clinicians, to enable them to better recognize the disease and to provide knowledge important for treatment and follow-up. The results provided the foundation for the international development of a COVID-19 specific patient-reported HRQoL questionnaire.

16 August 2022 in Journal of Clinical Oncology
Verified
Journal Article
Open access
AGAlexandra Gilbert
Alexandra Gilbert
CPClaire Piccinin
Claire Piccinin
GVGalina Velikova
Galina Velikova
MGMogens Groenvold
Mogens Groenvold
DKDagmara Kuliś
Dagmara Kuliś
ABAndrew Bottomley
Andrew Bottomley
PURPOSE: The European Organisation for Research and Treatment of Cancer (EORTC) Item Library is an interactive online platform currently composed of 950 unique items (questions) derived from 67 patient-reported outcome (PRO) questionnaires. PROs complement clinician adverse event (AE) reporting classifications like the Common Terminology Criteria for Adverse Events (CTCAE). This work aims to create a standardized framework using the CTCAE to systematically classify symptomatic AEs from the EORTC Item Library through linking individual items to corresponding AEs. METHODS: The EORTC Item Library items were searched for within the CTCAE (v5.0) and linked to an AE if they were described within the AE's title, description, or grading. Symptoms described in EORTC items but not located in the CTCAE were coded as missing symptoms. Other nonsymptom EORTC items, not described within the CTCAE were assigned a non-CTCAE descriptive classification. Further descriptive codes (eg, multiple issues) were allocated to enable descriptive analysis. Two raters independently coded 26.2% (n = 249) of the items. The remaining 701 items were coded by one rater and verified by the second, followed by discussion with two additional raters to reach consensus. RESULTS: Overall, 625 (65.8%) EORTC items were linked to 208 different AEs. Three hundred sixty-nine items provide information about non-CTCAE cancer–related issues and were categorized into seven descriptive classifications, including body image; emotional impact of a symptom, diagnosis, or treatment; global health and quality of life; and impact on life and daily activities. Inter-rater agreement for independent coding was 79.1%. Bowel urgency and tenesmus were identified as missing symptoms in CTCAEv5.0. CONCLUSION: The EORTC Item Library provides considerable coverage of CTCAE toxicities, along with other complementary issues important to patients with cancer. Using the CTCAE clinical framework to classify symptomatic PRO items may facilitate PRO selection and use in clinical trials and routine care.

24 September 2024 in eClinicalMedicine
Verified
Journal Article
Open access
CYChristina Yap
Christina Yap
OAOlalekan Lee Aiyegbusi
Olalekan Lee Aiyegbusi
EAEmily Alger
Emily Alger
EBEthan Basch
Ethan Basch
JBJill Bell
Jill Bell
JPJohn Devin Peipert
John Devin Peipert
Early phase clinical trials provide an initial evaluation of therapies’ risks and benefits to patients, including safety and tolerability, which typically relies on reporting outcomes by investigator and laboratory assessments. Use of patient-reported outcomes (PROs) to inform risks (tolerability) and benefits (improvement in disease symptoms) is more common in later than early phase trials. We convened a two-day expert roundtable covering: (1) the necessity and feasibility of a universal PRO core conceptual model for early phase trials; (2) the practical integration of PROs in early phase trials to inform tolerability assessment, guide dose decisions, or as real-time safety alerts to enhance investigator-reported adverse events. Participants (n = 22) included: patient advocates, regulators, clinicians, statisticians, pharmaceutical representatives, and PRO methodologists working across diverse clinical areas. In this manuscript, we report major recommendations resulting from the roundtable discussions corresponding to each theme. Additionally, we highlight priority areas necessitating further investigation.

19 February 2023 in Psycho-Oncology
Verified
Journal Article
Open access
MRMaria Rothmund-Grenier
Maria Rothmund-Grenier
MPMicha J. Pilz
Micha J. Pilz
NENathalie Egeter
Nathalie Egeter
ELEmma Lidington
Emma Lidington
CPClaire Piccinin
Claire Piccinin
EGEORTC Quality of Life Group
EORTC Quality of Life Group
Background: Cancer and its treatment can have substantial impact on patients' emotional functioning. Several patient‐reported outcome measures (PROMs) assessing emotional functioning are available, but differences in content limit the comparability of results. To better understand conceptual (dis)similarities, we conducted a content comparison of commonly used PROMs.Methods: We included emotional functioning items, scales, and item banks from the EORTC CAT Core, EORTC QLQ‐C30, FACT‐G, Hospital anxiety and depression scale (HADS), SF‐36, PRO‐CTCAE, and PROMIS (item banks for anxiety, depression, and anger). Item content was linked to the International Classification of Functioning, Disability, and Health (ICF) and a hierarchical framework established for PROMIS. Single items could be coded with more than one ICF category but were solely assigned to one facet within the PROMIS framework.Results: The measures comprise 132 unique items covering the ICF components ‘Body functions’ (136/153 codings, 88.9%) and ‘Activities and participation’ (15/153, 9.8%). Most ICF codings (112/153, 73.2%) referred to the third‐level category ‘b1528 Emotional functions, other specified’. According to the PROMIS framework 48.5% of the items assessed depression (64/132 items), followed by anxiety (41/132, 31.1%) and anger (26/132, 19.7%). The EORTC measures covered depression, anxiety, and anger in a single measure, while the PROMIS inventory provides separate item banks for these concepts. The FACT‐G, SF‐36, PRO‐CTCAE and HADS covered depression and anxiety, but not anger.Conclusion: Our results provide an in‐depth conceptual understanding of selected PROMs and important qualitative information going beyond psychometric evidence. Such information supports the identification of PROMs for which scores can be meaningfully linked with quantitative methods.

26 March 2022 in Journal of Patient-Reported Outcomes
Verified
Journal Article
Open access
PDF file
CACecilie Delphin Amdal
Cecilie Delphin Amdal
KTKatherine Taylor
Katherine Taylor
DKDagmara Kuliś
Dagmara Kuliś
RFRagnhild Sørum Falk
Ragnhild Sørum Falk
ABAndrew Bottomley
Andrew Bottomley
KBKristin Bjordal
Kristin Bjordal
Background: We aimed to create a questionnaire to assess the health-related quality of life including functioning, symptoms, and general health status of adult patients with current or previous COVID-19. Here, we report on Phase I and II of the development. Methods: Internationally recognized methodology for questionnaire development was followed. In Phase I, a comprehensive literature review was performed to identify relevant COVID-19 issues. Decisions for inclusion, exclusion, and data extraction were completed independently in teams of two and then compared. The resulting issues were discussed with health care professionals (HCPs) and current and former COVID-19 patients. The input of HCPs and patients was carefully considered, and the list of issues updated. In Phase II, this updated list was operationalized into items/questions. Results: The literature review yielded 3342 publications, 339 of which were selected for full-text review, and 75 issues were identified. Discussions with 44 HCPs from seven countries and 52 patients from six countries showed that psychological symptoms, worries, and reduced functioning lasted the longest for patients, and there were considerable discrepancies between HCPs and patients concerning the importance of some of the symptoms. The final list included 73 issues, which were operationalized into an 80-item questionnaire. Conclusion: The resulting COVID-19 questionnaire covers health–related quality of life issues relevant to COVID-19 patients and is available in several languages. The next steps include testing of the applicability and patients’ acceptability of the questionnaire (Phase IIIA) and preliminary psychometric testing (Phase IIIB).

31 March 2025 in European Journal of Cancer
Verified
Journal Article
Open access
CPClaire Piccinin
Claire Piccinin
NANeil K. Aaronson
Neil K. Aaronson
KBKristin Bjordal
Kristin Bjordal
CCCorneel Coens
Corneel Coens
ADAnne-Sophie Darlington
Anne-Sophie Darlington
MGMogens Groenvold
Mogens Groenvold
The development of the first European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) health-related quality of life (HRQoL) questionnaires contributed to the systematic uptake of HRQoL as an endpoint in cancer clinical trials, and to the measurement of HRQoL for individual assessment in routine care. Following a modular approach, these patient-reported outcome (PRO) measures (PROMs) ensure that both generic and disease-specific issues are assessed, enabling comparison of PROs across groups and studies. The application of a comprehensive and continually refined methodology for developing and updating these PROMs has been crucial in supporting their psychometric and cross-cultural validity, and their continued implementation in clinical research. However, the advancement of measurement science, the more widespread implementation of PROMs, and the significant evolution of anti-cancer therapies over the last decades have highlighted the need to adopt more flexible approaches to PRO assessment to ensure that PROMs remain relevant and fit-for-purpose. The QLG has responded to this call by implementing more tailored PRO measurement approaches through the development and release of the computerised adaptive test (CAT) version of the EORTC QLQ-C30 (i.e., the EORTC CAT Core) and the EORTC Item Library. The EORTC Item Library is an interactive online platform that allows for the creation of customised questionnaires (item lists) from the pool of available items derived from established EORTC QLG PROMs. The aim of this article is to describe the current EORTC QLG approach to PRO measurement in oncology, covering important historical developments and best practice recommendations.